Lessons on drug development: a literature review of challenges faced in nonalcoholic fatty liver disease (NAFLD) clinical trials
NAFLD is the most common chronic liver disease worldwide, occurring in both obese and lean patients. It can lead to life-threatening liver diseases and nonhepatic complications, such as cirrhosis and cardiovascular diseases, that burden public health and the health care system. Current care is weigh...
Saved in:
Main Authors: | Chen, Joel Yeh Siang, Chua, Damien, Lim, Carissa Odelia, Ho, Wan Xi, Tan, Nguan Soon |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Article |
Language: | English |
Published: |
2023
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/165607 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study.
by: Tan, Eunice Xiang-Xuan, et al.
Published: (2021) -
Insights into the role of PPARβ/δ in NAFLD
by: Tan, Nguan Soon, et al.
Published: (2018) -
NAFLD HUMAN IN-VITRO MODEL FOR NOVEL THERAPEUTIC TARGETS INVESTIGATION
by: LAM DO THUY UYEN HA
Published: (2024) -
Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: The GOASIA study
by: Pitisuttithum, P., et al.
Published: (2021) -
Gut-liver axis in nonalcoholic fatty liver disease (NAFLD)
by: Koo, Yolanda Wei Ling
Published: (2023)